Showing results (41-50 of 101) with videos related to
Sort By:
Pageof 11
Journal of the Peripheral Nervous System : JPNS|December 20, 2011
HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patientsSimona Capponi, Alessandro Geroldi, Paola Fossa, et al.International Journal of Molecular Sciences|June 10, 2023
Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 InhibitorsNaomi Scarano, Elena Abbotto, Francesca Musumeci, et al.Bioorganic & Medicinal Chemistry|November 3, 2009
Synthesis of 4-thiophen-2'-yl-1,4-dihydropyridines as potentiators of the CFTR chloride channelFrancesca Cateni, Marina Zacchigna, Nicoletta Pedemonte, et al.Chemical Biology & Drug Design|July 5, 2017
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligandsBattistina Asproni, Ilaria Manca, Giansalvo Pinna, et al.Bioorganic & Medicinal Chemistry Letters|November 29, 2016
Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitorsSara Guariento, Anna Karawajczyk, James A Bull, et al.International Journal of Molecular Sciences|April 5, 2020
Recent Strategic Advances in CFTR Drug Discovery: An OverviewMarco Rusnati, Pasqualina D'Ursi, Nicoletta Pedemonte, et al.Journal of Medicinal Chemistry|August 16, 2014
Synthesis, biological evaluation, and molecular modeling of new 3-(cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) related phosphodiesterase 4D (PDE4D) inhibitorsChiara Brullo, Matteo Massa, Massimo Rocca, et al.International Journal of Molecular Sciences|November 3, 2020
Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR CorrectorsGiada Righetti, Monica Casale, Nara Liessi, et al.European Journal of Human Genetics : EJHG|March 19, 2009
Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathiesPaola Mandich, Paola Fossa, Simona Capponi, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 31, 2017
New arylsparteine derivatives as positive inotropic drugsVito Boido, Marcella Ercoli, Michele Tonelli, et al.Pageof 11